Claims that China has developed an anti-aging drug capable of extending human life to 150 years are not scientifically proven.
The reports are based on research by a Chinese biotech startup, Lonvi Biosciences, which is studying a compound called Procyanidin C1 (PCC1), derived from grape seed extract. PCC1 targets senescent or “zombie” cells that accumulate with age and contribute to inflammation and age-related diseases.
In laboratory studies, PCC1 improved health and modestly extended lifespan in mice, which has fueled optimism about its potential in humans.
However, no human clinical trials have shown that this or any drug can dramatically extend human lifespan, let alone to 150 years. The figure comes from optimistic projections by company executives, not medical evidence.
In summary, China has made promising early advances in anti-aging research, but a pill that can extend human life to 150 years does not currently exist. The claim remains speculative and far ahead of proven science.